Richard W. Mott, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), bought 240,000 shares at $4.57 ($1.1M) on 2024-05-10, disclosed to the SEC on 2024-05-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.57 | 83,198 | $380K | 35.1% |
| 2 | $4.57 | 83,198 | $380K | 35.1% |
| 3 | $4.38 | 36,802 | $161K | 14.9% |
| 4 | $4.38 | 36,802 | $161K | 14.9% |
| Total | $4.51 avg | 240,000 | $1.1M | 100% |
| Filing → |
| TMCI | SELL | 2023-04-10 | $105K | — | Filing → |
| TMCI | SELL | 2023-04-05 | $415K | — | Filing → |
| TMCI | SELL | 2023-03-31 | $3.4M | — | Filing → |